WWB timeline
Every WWB batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| WWB-2607-X2189 | Liraglutide | 02 Jul 2026 | 2026-Q3 | 5 | 99.61 | 0.78 | 99.90 | +0.29 | |
| WWB-2606-N3192 | Semaglutide | 27 Jun 2026 | 2026-Q3 | 15 | 99.09 | 0.96 | 99.90 | +0.81 | |
| WWB-2606-H3906 | BPC-157 | 01 Jun 2026 | 2026-Q3 | 14 | 99.46 | 0.98 | 99.90 | +0.44 | |
| WWB-2604-E3153 | Ipamorelin | 20 Apr 2026 | 2026-Q2 | 10 | 99.93 | 0.21 | 99.90 | -0.03 | |
| WWB-2604-J2590 | Semaglutide | 10 Apr 2026 | 2026-Q2 | 4 | 99.63 | 0.87 | 99.77 | +0.14 | |
| WWB-2604-B3510 | BPC-157 | 03 Apr 2026 | 2026-Q2 | 6 | 99.93 | 0.06 | 99.90 | -0.03 | |
| WWB-2604-T3876 | Tirzepatide | 01 Apr 2026 | 2026-Q2 | 4 | 99.73 | 0.84 | 99.30 | -0.43 | |
| WWB-2603-N3120 | Semaglutide | 09 Mar 2026 | 2026-Q2 | 15 | 98.98 | 1.94 | 99.46 | +0.48 | |
| WWB-2603-W2120 | Semaglutide | 03 Mar 2026 | 2026-Q2 | 4 | 99.61 | 0.45 | 99.90 | +0.29 | |
| WWB-2602-M2472 | Semaglutide | 24 Feb 2026 | 2026-Q3 | 3 | 99.37 | 0.70 | 99.90 | +0.53 | |
| WWB-2602-G2822 | Epitalon | 24 Feb 2026 | 2026-Q2 | 1 | 99.75 | n<2 | 99.63 | -0.12 | |
| WWB-2602-L4102 | Ipamorelin | 23 Feb 2026 | 2026-Q1 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| WWB-2602-U1840 | L-Glutathione (reduced) | 18 Feb 2026 | 2026-Q1 | 5 | 99.28 | 1.22 | 99.90 | +0.62 | |
| WWB-2602-X2511 | Semaglutide | 15 Feb 2026 | 2026-Q1 | 2 | 98.27 | 1.20 | 98.75 | +0.48 | |
| WWB-2602-S2129 | Thymulin | 14 Feb 2026 | 2026-Q2 | 13 | 99.12 | 0.87 | 99.50 | +0.38 | |
| WWB-2601-V1583 | NAD+ | 31 Jan 2026 | 2026-Q2 | 6 | 99.63 | 0.89 | 99.90 | +0.27 | |
| WWB-2601-C4091 | Dihexa | 28 Jan 2026 | 2026-Q2 | 1 | 99.49 | n<2 | 99.90 | +0.41 | |
| WWB-2601-J2662 | Tirzepatide | 26 Jan 2026 | 2026-Q1 | 2 | 99.34 | 0.03 | 99.81 | +0.47 | |
| WWB-2601-C3477 | Ipamorelin | 19 Jan 2026 | 2026-Q1 | 5 | 99.45 | 0.99 | 99.90 | +0.45 | |
| WWB-2601-E2735 | TB-500 | 07 Jan 2026 | 2026-Q1 | 5 | 99.80 | 0.35 | 99.90 | +0.10 | |
| WWB-2512-B1996 | GHK-Cu | 14 Dec 2025 | 2026-Q2 | 7 | 99.42 | 1.08 | 99.76 | +0.34 | |
| WWB-2512-R4093 | Adipotide | 10 Dec 2025 | 2026-Q2 | 9 | 98.83 | 1.21 | 99.48 | +0.65 | |
| WWB-2512-S4435 | Retatrutide | 08 Dec 2025 | 2026-Q2 | 5 | 98.40 | 1.29 | 99.34 | +0.94 | |
| WWB-2512-T3671 | Semaglutide | 02 Dec 2025 | 2026-Q2 | 4 | 98.97 | 1.00 | 99.50 | +0.53 | |
| WWB-2511-K4194 | GHRP-2 | 27 Nov 2025 | 2026-Q1 | 6 | 99.75 | 0.42 | 99.90 | +0.15 | |
| WWB-2511-J1983 | Tirzepatide | 19 Nov 2025 | 2026-Q1 | 2 | 99.03 | 0.11 | 99.67 | +0.64 | |
| WWB-2511-L4181 | Pramlintide | 18 Nov 2025 | 2025-Q4 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| WWB-2511-S3009 | ARA-290 | 16 Nov 2025 | 2026-Q1 | 10 | 99.93 | 0.51 | 99.90 | -0.03 | |
| WWB-2511-M1961 | Ipamorelin | 07 Nov 2025 | 2026-Q2 | 3 | 99.93 | 0.26 | 99.90 | -0.03 | |
| WWB-2511-C2485 | GHRP-6 | 06 Nov 2025 | 2025-Q4 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| WWB-2510-R2141 | Survodutide | 22 Oct 2025 | 2026-Q1 | 2 | 98.84 | 0.45 | 99.33 | +0.49 | |
| WWB-2510-P2932 | Melanotan II | 20 Oct 2025 | 2025-Q4 | 7 | 99.54 | 0.85 | 99.90 | +0.36 | |
| WWB-2510-H1662 | Retatrutide | 09 Oct 2025 | 2026-Q1 | 11 | 99.22 | 1.14 | 99.83 | +0.61 | |
| WWB-2510-P4387 | Tirzepatide | 02 Oct 2025 | 2025-Q4 | 2 | 99.22 | 0.17 | 99.66 | +0.44 | |
| WWB-2509-J2476 | Liraglutide | 14 Sep 2025 | 2025-Q4 | 1 | 99.76 | n<2 | 99.90 | +0.14 | |
| WWB-2509-A4716 | PT-141 (Bremelanotide) | 04 Sep 2025 | 2026-Q1 | 11 | 99.93 | 0.44 | 99.90 | -0.03 | |
| WWB-2509-J2816 | CJC-1295 with DAC | 01 Sep 2025 | 2025-Q4 | 14 | 99.19 | 0.77 | 99.90 | +0.71 | |
| WWB-2508-X3536 | TB-500 | 30 Aug 2025 | 2026-Q1 | 1 | 99.42 | n<2 | 99.90 | +0.48 | |
| WWB-2508-V3100 | CJC-1295 with DAC | 18 Aug 2025 | 2026-Q1 | 11 | 99.80 | 0.63 | 99.90 | +0.10 | |
| WWB-2508-S3298 | Semaglutide | 18 Aug 2025 | 2026-Q1 | 6 | 99.01 | 1.28 | 99.90 | +0.89 | |
| WWB-2507-N1598 | Dihexa | 28 Jul 2025 | 2025-Q3 | 2 | 99.93 | 0.00 | 99.90 | -0.03 | |
| WWB-2507-V2845 | Semaglutide | 24 Jul 2025 | 2025-Q4 | 5 | 98.98 | 0.45 | 99.25 | +0.27 | |
| WWB-2507-X4677 | SS-31 (Elamipretide) | 01 Jul 2025 | 2025-Q3 | 1 | 99.71 | n<2 | 99.90 | +0.19 | |
| WWB-2507-K2916 | MOTS-c | 01 Jul 2025 | 2025-Q3 | 2 | 99.93 | 0.00 | 99.90 | -0.03 | |
| WWB-2506-S4098 | Semax | 25 Jun 2025 | 2025-Q4 | 10 | 99.68 | 1.08 | 99.90 | +0.22 | |
| WWB-2506-T2732 | Tirzepatide | 03 Jun 2025 | 2025-Q4 | 10 | 99.73 | 1.57 | 99.32 | -0.41 | |
| WWB-2505-N4242 | IGF-1 DES (1-3) | 30 May 2025 | 2025-Q4 | 2 | 99.32 | 0.60 | 99.61 | +0.29 | |
| WWB-2505-G2801 | MOTS-c | 19 May 2025 | 2025-Q3 | 10 | 99.47 | 0.79 | 99.90 | +0.43 | |
| WWB-2505-R4660 | Tirzepatide | 17 May 2025 | 2025-Q3 | 2 | 99.17 | 0.60 | 99.90 | +0.73 | |
| WWB-2505-H4240 | TB-500 | 12 May 2025 | 2025-Q3 | 1 | 99.69 | n<2 | 99.90 | +0.21 | |
| WWB-2504-J3824 | IGF-1 LR3 | 27 Apr 2025 | 2025-Q3 | 2 | 98.55 | 0.50 | 98.83 | +0.28 | |
| WWB-2504-B2388 | NAD+ | 02 Apr 2025 | 2025-Q2 | 3 | 99.70 | 0.28 | 100.00 | +0.30 | |
| WWB-2504-F3053 | TB-500 | 01 Apr 2025 | 2025-Q3 | 1 | 99.69 | n<2 | 99.73 | +0.04 | |
| WWB-2503-Y3157 | Mazdutide | 25 Mar 2025 | 2025-Q3 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| WWB-2503-U2989 | CJC-1295 with DAC | 09 Mar 2025 | 2025-Q2 | 1 | 99.50 | n<2 | 99.90 | +0.40 | |
| WWB-2502-W1846 | Semaglutide | 26 Feb 2025 | 2025-Q1 | 8 | 99.00 | 1.22 | 99.64 | +0.64 | |
| WWB-2502-F3190 | BPC-157 | 22 Feb 2025 | 2025-Q1 | 3 | 99.93 | 0.00 | 99.90 | -0.03 | |
| WWB-2502-U2990 | Tirzepatide | 19 Feb 2025 | 2025-Q1 | 12 | 99.33 | 1.59 | 99.81 | +0.48 | |
| WWB-2501-S2183 | Semaglutide | 26 Jan 2025 | 2025-Q1 | 8 | 99.32 | 0.98 | 99.73 | +0.41 | |
| WWB-2501-K3141 | Semaglutide | 21 Jan 2025 | 2025-Q1 | 7 | 98.69 | 1.05 | 98.73 | +0.04 | |
| WWB-2501-L3929 | L-Glutathione (reduced) | 11 Jan 2025 | 2025-Q2 | 2 | 99.86 | 0.00 | 99.74 | -0.12 | |
| WWB-2501-Y4287 | TB-500 | 09 Jan 2025 | 2025-Q2 | 9 | 99.80 | 0.64 | 99.90 | +0.10 | |
| WWB-2501-Y2776 | Semaglutide | 07 Jan 2025 | 2025-Q1 | 12 | 99.23 | 1.52 | 99.78 | +0.55 | |
| WWB-2412-N4087 | Retatrutide | 14 Dec 2024 | 2025-Q1 | 10 | 99.26 | 0.81 | 99.90 | +0.64 | |
| WWB-2411-A2303 | Tirzepatide | 15 Nov 2024 | 2025-Q1 | 3 | 99.37 | 0.21 | 99.45 | +0.08 | |
| WWB-2411-X3830 | MK-677 (Ibutamoren mesylate) | 10 Nov 2024 | 2025-Q1 | 10 | 99.74 | 0.72 | 99.90 | +0.16 | |
| WWB-2410-J3284 | Semaglutide | 25 Oct 2024 | 2025-Q1 | 6 | 99.93 | 0.98 | 99.90 | -0.03 | |
| WWB-2410-D2737 | Semaglutide | 16 Oct 2024 | 2024-Q4 | 12 | 99.20 | 1.02 | 99.57 | +0.37 | |
| WWB-2408-E1643 | GHRP-6 | 29 Aug 2024 | 2024-Q3 | 2 | 99.80 | 0.26 | 99.90 | +0.10 | |
| WWB-2408-E4076 | Afamelanotide | 20 Aug 2024 | 2025-Q1 | 1 | 99.28 | n<2 | 99.90 | +0.62 | |
| WWB-2408-B4507 | MK-677 (Ibutamoren mesylate) | 17 Aug 2024 | 2024-Q4 | 7 | 99.93 | 0.29 | 99.90 | -0.03 | |
| WWB-2408-T2155 | BPC-157 | 12 Aug 2024 | 2025-Q1 | 3 | 99.93 | 0.20 | 99.90 | -0.03 | |
| WWB-2408-T3710 | Survodutide | 09 Aug 2024 | 2024-Q4 | 11 | 99.13 | 1.33 | 99.32 | +0.19 | |
| WWB-2408-X2078 | Retatrutide | 03 Aug 2024 | 2024-Q4 | 9 | 98.88 | 0.81 | 99.90 | +1.02 | |
| WWB-2406-R3462 | Liraglutide | 25 Jun 2024 | 2024-Q3 | 13 | 99.48 | 1.24 | 99.78 | +0.30 | |
| WWB-2406-Y1595 | Afamelanotide | 03 Jun 2024 | 2024-Q4 | 6 | 99.53 | 0.73 | 99.90 | +0.37 | |
| WWB-2405-W1240 | Retatrutide | 15 May 2024 | 2024-Q3 | 2 | 99.01 | 0.02 | 99.12 | +0.11 | |
| WWB-2403-J3152 | Tirzepatide | 20 Mar 2024 | 2024-Q3 | 10 | 98.34 | 0.91 | 99.01 | +0.67 | |
| WWB-2402-G4573 | Oxytocin | 19 Feb 2024 | 2024-Q3 | 3 | 99.93 | 0.00 | 99.90 | -0.03 | |
| WWB-2401-U3578 | GHRP-6 | 15 Jan 2024 | 2024-Q2 | 11 | 99.93 | 0.16 | 99.90 | -0.03 | |
| WWB-2312-E2908 | Desmopressin | 27 Dec 2023 | 2024-Q1 | 8 | 99.77 | 0.78 | 99.90 | +0.13 | |
| WWB-2312-S1875 | KPV | 14 Dec 2023 | 2024-Q2 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| WWB-2312-P4483 | Afamelanotide | 08 Dec 2023 | 2024-Q1 | 8 | 99.76 | 0.84 | 99.90 | +0.14 | |
| WWB-2311-T3203 | Kisspeptin-10 | 05 Nov 2023 | 2024-Q2 | 13 | 99.86 | 0.97 | 99.88 | +0.02 | |
| WWB-2310-A4053 | IGF-1 LR3 | 22 Oct 2023 | 2024-Q1 | 10 | 98.96 | 0.88 | 99.75 | +0.79 | |
| WWB-2308-N1754 | Semax | 24 Aug 2023 | 2024-Q1 | 14 | 99.51 | 1.05 | 99.90 | +0.39 |